Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06548321

Benefits of Extracorporeal Shockwave Therapy to Reduce Spasticity in Stroke/CP

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Superior University · Academic / Other
Sex
All
Age
10 Years – 50 Years
Healthy volunteers
Accepted

Summary

This Study will help to explain us that ExtracorporealShockwave therapy can reduce spasticity in Stroke Patient,help them to restore their abilities and ROM.Therapy reduces dependency rate of patient.Also seen this therapy shows reduction in spasticity of CP child population.Improving the motor recovery.

Detailed description

ESWT therapy increses molecular and immunological reactions,increase blood microcirculation and neurovascularization.It enhancing the neural proliferation of neural stem cell(NSC),which shows repair in brain function in CNS diseases.Extracorporeal shockwave can produce Nitric oxide in enzymatic and non enzymatic way which help, to reduce muscle spasm.Extracorporeal Shockwave reduce the exitibilty of motor neuron by vibratory stimulation of tendon and reduces tension.After 2 weeks ESWT muscle tension reduces increases range of motion reduces the pain.shock wave therapy appears to be effective in reducing spasticity levels irrespective of the age of the participants, the type of injury, and the tool used to measure the effect.ESWT change in motor neuron exitibilty \& also associated with the spastic muscle.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTExtracorporeal Shockwave Therapy" The ESTW machine is turned on and the instrument, or shockwave gun, is pressed against the affected area. Rapid impulses are then delivered to the patient. Treatment typically lasts between 5 and 15 minutes. While this treatment can be uncomfortable for some, most do not experience any pain. Once treatment is completed, patients should do their best to physical activity… higher levels of energy Shockwaves into deeper tissue locations… ESWT therapies can help treat neurological disorders like multiple sclerosis and the effects of stroke.

Timeline

Start date
2023-10-01
Primary completion
2024-05-01
Completion
2024-09-30
First posted
2024-08-12
Last updated
2024-08-12

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06548321. Inclusion in this directory is not an endorsement.